非转染人角膜上皮细胞系的建立、鉴定及其克隆化研究
[Abstract]:Corneal blindness is a common cause of blindness, and more than 4 million patients are in need of treatment in China. Many of these patients were blind due to irreversible changes in human corneal epithelium (HCEP). Although it can be cured by the donation of a corneal graft, it is limited to a serious shortage of the amount of the donor cornea, which makes the vast majority of the patients unable to see the light. Tissue engineering human corneal epithelium (TE-HCEP), as an equivalent substitute for HCEP, is an effective way to solve the problem of insufficient donor cornea and most of the HCEP abnormal patients. The key elements of TE-HCEP in vitro reconstruction include the preparation of the HCEP seed cells with normal structural function and the preparation of the carrier stent with the desired biocompatibility. How to obtain a large number of seed cells that meet the requirements for in vitro reconstruction of TE-HCEP is one of the hot spots in the study. Consecutive human corneal epithelial cells can provide a large number of human corneal epithelial cells (HCEPC), considered to be the ideal source of seed cells, and the HCEPC cell line that has been established is an immortalized cell line transfected with an oncogene due to its potential tumorigenicity, Can't be applied to clinical transplant. The establishment of HCEPC cell line by non-transfection method can provide a sufficient number of normal cells for the in vitro reconstruction of TE-HCEP, but no report of the cell line is established without the transfection of the HCEPC. In order to solve the source problem of the large number of HCEP seed cells required for the in vitro reconstruction of TE-HCEP and the whole-layer cornea, the HCEPC cell line is established by the non-transfection method, in order to create the conditions for the in vitro reconstruction of the TE-HCEP and the whole-layer cornea. In order to establish a non-transfected HCEPC cell line, according to the structural characteristics of human corneal tissue, after enzymatic hydrolysis of the torn human corneal epithelial layer with 0.25% trypsin solution, the upper leather surface was directly applied to the 24-hole plate treated with 0. 01% gelatin, and then added with bFGF, EGF and sulfuric acid after 12h. DMEM/ F12 complete culture solution (20% fetal bovine serum) of osteopsin, permethyl shell polysaccharide and type IV collagen, cultured in a 37 & deg; C, 5% CO2 incubator, and the primary culture of HCEPC was initiated in that culture condition, after the primary start of 3d, i. e., the cell is removed, and the cell monolayer is grown, and the cell is a typical epithelial-like cell, and the cell is a typical epithelial-like cell, and the growth and division are vigorous, and the cells can be stably passaged, and the cells that are recovered after the freeze-storage can still maintain good growth state and proliferation. The cell growth was still good after successive successive generations (over 60 generations), and the non-transfection of the HCEPC cell line was completed. Establishment. The cell property identification of the continuous passage HCEPC is to determine that the established cell line is a HCEPC fine The key of the cell line is that the 90th generation cells of the non-transfected HCEPC cell line, which have been established, were observed by morphological observation, growth characteristic detection, chromosome analysis, cell immunofluorescence and tumorigenicity. The morphological identification of the cell, including the observation of the light and the scanning electron microscope, showed that the cell line of the cell line had a typical epithelial-like cell morphology, and the cell surface was rich in micro-organisms. The results of the analysis of the growth characteristics of the cell line showed that the population doubling time of the cell line was 40. 56h, and the cell division was The number of the characteristic chromosomes of the cell line is 2n = 46, and the chromosome number of the cell line of the cell line is 2n = 46, and the number of the chromosomes has been found. The results of the immunofluorescence test of the HCEP-specific marker protein showed that the cell line cells had positive expression of the cytokeratin K3, K12 and K19, and combined with the results of the karyotype analysis, it was possible to preliminarily determine that the non-transfected cell line established in this paper is the HCE. PC cell line. The results of the tumorigenicity test showed that the cell line did not The cell line established in this article is a non-transfected, non-tumorigenic HCE. PC cell line. In order to screen the normal HCEPC for the number of chromosomes to use HCEP seed cells, this paper uses the established non-transfected HCEPC cell line The cloning of HCEPC cell line was carried out by using a limited dilution method. The cell of HCEPC cell line was cloned and amplified by the mouse peritoneal macrophages, and the monoclonal cell line was selected for chromosome group analysis. A monoclonal cell line with 2n = 46 normal karyotype was selected, named HCEP-5. A1, the cell of the monoclonal cell line is frozen and then recovered, The growth state is good. The expression of the HCEP marker protein, the connexin and the functional protein of the monoclonal cell line cell is detected by immunofluorescence, and the result shows that it has the positive expression of K3 and K12 to prove the HCEPC property, and has the gap connection protein-43 and the whole-linked egg. The positive expression of the white antigen 1 indicates that it has the potential to form a cell communication connection and an anchor connection, can form a complete human corneal epithelial layer, and has a positive expression of a calcium pump PMCA1/ 4 protein and a 14-3-3s protein, indicating that it is provided with a cross-membrane transport and a shape of a normal HCEPC. thus, the screened HCEP-5A1 monoclonal cell line meets the condition that the HCEP-5A1 monoclonal cell line is used as the HCEP seed cell, and can be used for TE-H In conclusion, the non-transfectively non-tumorigenic HCEPC cell line was successfully established, and the normal HCEP seed cells of the chromosome group were selected, the origin of the HCEP seed cell was solved, the in vitro reconstruction of TE-HCEP and the full-angle of the tissue engineering were solved.
【学位授予单位】:中国海洋大学
【学位级别】:硕士
【学位授予年份】:2012
【分类号】:R318.18
【相似文献】
相关期刊论文 前10条
1 曾思聪;周兟;卢光t;;端粒酶shRNA慢病毒载体的构建及转染人类胚胎干细胞[J];现代生物医学进展;2011年08期
2 李栋;聂代邦;王海军;段新平;逄大欣;欧阳红生;;Fat-1基因真核表达载体的构建及其对人口腔鳞癌细胞脂肪酸含量的影响[J];现代生物医学进展;2011年11期
3 周建民;丁国富;王勤章;刘新军;刘永国;;应用AdMax载体系统构建SCL基因重组腺病毒表达载体[J];中国现代医学杂志;2011年17期
4 史册;孙宏晨;李琛;陈彦泽;;腺病毒介导TWEAK基因对破骨细胞影响的体外研究[J];实用口腔医学杂志;2011年04期
5 周斌;傅丰庆;徐俊驰;沈宇;高菲;张学光;;人TLT-2真核表达载体的构建及其在L929细胞株中的稳定转染[J];苏州大学学报(医学版);2011年03期
6 沈培;郑东;刘艳;田洁;赵银霞;刘青玲;朱晨露;马洁;苏兆亮;马斌;许化溪;王胜军;;小鼠GITR真核表达载体的构建及表达[J];江苏大学学报(医学版);2011年04期
7 朱春晖;谢勇;吕农华;;外源性野生型p53基因对sw1990细胞调控基因表达的影响[J];郑州大学学报(医学版);2011年04期
8 顾立学;罗俊生;王瑞;冯旭;关宁;霍晓川;;人胆固醇酯水解酶真核表达载体的构建及U937细胞系的转染[J];山东医药;2011年26期
9 王海红;董为人;张琳;晏芳;刘忠英;李妍;;真核表达质粒pcDNA3.1-tau的构建及在HEK293细胞中的稳定表达[J];中国组织工程研究与临床康复;2011年28期
10 祖谷;陈乔尔;胡芳芳;方丽;;Fas基因转染联合应用顺铂对舌鳞癌细胞的杀伤作用[J];安徽医科大学学报;2011年09期
相关会议论文 前10条
1 傅新巧;张苏明;褚倩;肖文伍;;大鼠骨髓间充质干细胞转染人TH基因的实验研究[A];中华医学会第七次全国神经病学学术会议论文汇编[C];2004年
2 王锡山;赵旭海;王轶慧;姜世雄;;肽核酸(PNA)对大肠癌LS-174T细胞生长影响的实验研究[A];第四届中国肿瘤学术大会暨第五届海峡两岸肿瘤学术会议论文集[C];2006年
3 李建军;陈延治;李光;顾菲;王志宇;辛彦;;外源性PTEN增强放射线诱导胰腺癌ASPC-1细胞G_2/M期阻滞[A];第四届中国肿瘤学术大会暨第五届海峡两岸肿瘤学术会议论文集[C];2006年
4 刘颜颜;武军驻;何春燕;李小明;;人a-保护素1在细胞氧化低密度脂蛋白中的作用[A];湖北省暨武汉市生物化学与分子生物学学会第八届第十七次学术年会论文汇编[C];2007年
5 叶芳;张岚;杨涛;乔振华;杨林花;;人全长Survivin表达载体的构建及转染K562细胞[A];第12届全国实验血液学会议论文摘要[C];2009年
6 祁丽;邢丽娜;马景光;;转染VEGF-C反义寡核苷酸对宫颈癌Hela细胞增殖和调亡的影响[A];中华医学会放射肿瘤治疗学分会六届二次暨中国抗癌协会肿瘤放疗专业委员会二届二次学术会议论文集[C];2009年
7 车兴华;陈洪;徐振明;尚超;孙开来;富伟能;;14-3-3epsilon通过影响癌细胞凋亡及侵袭能力在喉癌中发挥抑癌作用[A];北方遗传资源的保护与利用研讨会论文汇编[C];2010年
8 张书霞;步志高;陈万芳;;鸡bcl—2表达质粒的构建及其对转染细胞凋亡的影响[A];中国畜牧兽医学会兽医病理学分会第十一次兽医病理学、第十次动物病理生理学学术研讨会论文集[C];2001年
9 刘旭;李殿俊;田长富;李天天;;腺病毒介导的hIL-2基因转染肿瘤细胞的生物学特性研究[A];第七届全国肿瘤生物治疗学术会议论文集[C];2001年
10 郑义;史斌;崔建英;;逆转录病毒介导多药抗性基因转染脐带血CD34+细胞[A];第三届全国血液免疫学学术大会论文集[C];2003年
相关重要报纸文章 前10条
1 冯世容;CD95基因转染可提高胰腺癌对化疗药物敏感性[N];中国医药报;2001年
2 白毅;上海创建大规模细胞DNA转染技术平台[N];中国医药报;2005年
3 张中桥;NDRG2可诱导肝癌细胞HepG2凋亡[N];中国医药报;2004年
4 吴一福;PTFE血管材料可携载VEGF基因转染[N];中国医药报;2006年
5 张中桥;反义Cortactin基因能抑制肝癌细胞转移[N];中国医药报;2006年
6 高国起;膀胱癌基因治疗新技术[N];科技日报;2003年
7 吴一福;四医大建成出血热B淋巴母细胞样细胞系[N];中国医药报;2006年
8 吴一福;川大成功建立人新基因PCIA1细胞株[N];中国医药报;2006年
9 吴军 杨太成;主动特异性免疫疗法治疗肿瘤[N];中国中医药报;2003年
10 张中桥;第四军医大学西京医院实现肿瘤特异性RNA干扰[N];中国医药报;2006年
相关博士学位论文 前10条
1 王芳;整合素连接激酶在胎盘血管性疾病中的作用研究[D];华中科技大学;2012年
2 郎莉莉;MD-2在人角膜上皮细胞应答LPS刺激中的作用研究[D];第二军医大学;2010年
3 纪敏;MCL1、AF1q和microRNA在白血病中的作用及其机制研究[D];山东大学;2011年
4 刘栋良;基因载体阳离子类脂设计合成及生物性能研究[D];大连理工大学;2006年
5 罗文娟;人血小板源性生长因子基因B转染体外培养猫角膜内皮细胞的生物学效应[D];青岛大学;2005年
6 任晓勇;人生长分化因子-5基因转染骨髓间充质干细胞及用于软骨缺损修复的初步研究[D];第四军医大学;2005年
7 李晖;Toll样受体和NF-κB在HSV-1感染人角膜上皮细胞天然免疫反应中的作用[D];武汉大学;2004年
8 赵福杰;转染反义c-erbB-2 mRNA对子宫内膜癌ISHIKAWA及HEC-1A细胞株生长抑制作用的研究[D];中国医科大学;2006年
9 李辉南;rhIGF-1对去卵巢大鼠骨质疏松治疗作用的实验研究[D];吉林大学;2006年
10 梁显军;p16基因转染对大肠癌细胞周期及放射敏感性的实验研究[D];吉林大学;2008年
相关硕士学位论文 前10条
1 王瑞鑫;非转染人角膜上皮细胞系的建立、鉴定及其克隆化研究[D];中国海洋大学;2012年
2 陈娟;外源蛋白在柔嫩艾美耳球虫卵囊中的瞬时表达[D];中国农业大学;2005年
3 张宏涛;NF-κB诱捕物寡聚核苷酸对大鼠移植肾早期炎性损伤的影响[D];郑州大学;2005年
4 何小宁;人溶菌酶基因乳腺特异性表达载体的构建及其在小鼠乳腺癌细胞中的表达[D];西北农林科技大学;2006年
5 刘萍;口蹄疫病毒3C基因的真核表达及其诱导宿主细胞凋亡的研究[D];甘肃农业大学;2007年
6 黄旋平;hBMP-2真核表达载体的构建及转染兔骨髓间充质干细胞的研究[D];广西医科大学;2007年
7 刘春江;大鼠胎脑神经干细胞的分离培养及电穿孔转染[D];中南大学;2009年
8 萧平难;稳定过表达BAALC基因的人白血病细胞株的建立及其生物学活性研究[D];南方医科大学;2010年
9 李t$;肺癌细胞总RNA转染DC体外诱导肺癌患者抗瘤免疫的实验研究[D];天津医科大学;2002年
10 陈幸德;猪干扰素-γ基因的克隆及其表达[D];中国农业大学;2003年
,本文编号:2321887
本文链接:https://www.wllwen.com/yixuelunwen/swyx/2321887.html